NCT00755989

Brief Summary

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2009

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 19, 2008

Completed
6 months until next milestone

Study Start

First participant enrolled

April 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

July 20, 2025

Status Verified

February 1, 2025

Enrollment Period

1 year

First QC Date

September 18, 2008

Last Update Submit

July 16, 2025

Conditions

Wounds

Outcome Measures

Primary Outcomes (1)

  • Safety and efficacy with the use of morphine gel applied topically for pain control

    1 year

Study Arms (1)

Arm Title 1

OTHER

None available - study is no longer active.

Other: None available

Interventions

None availableOTHER
Also known as: STudy is no longer active
Arm Title 1

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed and dated consent form \& HIPAA
  • \>/= 18 yo
  • Single stage 2-3 wound evaluated by our wound care team
  • Alert and oriented (thinking ability clear and intact, physician approval)
  • English language proficiency, likely to be able to participate in all scheduled evaluations

You may not qualify if:

  • Allergy to morphine, codeine, or versa base
  • pts taking medications for acute condition, other than for the wound pain (can be taking chronic pain meds if current dose stable for past 3 mo)
  • Patients with neuropathies
  • Patients with respiratory conditions
  • Patients that are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banner Good Samaritan Medical Center

Phoenix, Arizona, 85006, United States

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Mary Whitmer, MSN,FNP, APRN BC-PCM

    Banner Health

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
DOUBLE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2008

First Posted

September 19, 2008

Study Start

April 1, 2009

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

July 20, 2025

Record last verified: 2025-02

Locations

US(1)